Evolent Health Inc (EVH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.19 is considered Undervalued compared with the five-year average of 44.54. The fair price of Evolent Health Inc (EVH) is between 12.73 to 30.61 according to relative valuation method. Compared to the current price of 3.31 USD , Evolent Health Inc By Undervalued By 73.99%.

Relative Value

Fair Zone

12.73-30.61

Current Price：3.31

73.99%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Evolent Health Inc (EVH) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Evolent Health Inc (EVH) has a current Price-to-Book (P/B) ratio of 0.52. Compared to its 3-year average P/B ratio of 2.23, the current P/B ratio is approximately -76.94% higher. Relative to its 5-year average P/B ratio of 2.85, the current P/B ratio is about -81.91% higher. Evolent Health Inc (EVH) has a Forward Free Cash Flow (FCF) yield of approximately -26.72%. Compared to its 3-year average FCF yield of -1.04%, the current FCF yield is approximately 2475.06% lower. Relative to its 5-year average FCF yield of -1.39%, the current FCF yield is about 1828.53% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for EVH competitors is 0.61, providing a benchmark for relative valuation. Evolent Health Inc Corp (EVH.N) exhibits a P/S ratio of 0.19, which is -68.09% above the industry average. Given its robust revenue growth of -27.50%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of EVH increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of EVH in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is EVH currently overvalued or undervalued?

What is Evolent Health Inc (EVH) fair value?

EVH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Evolent Health Inc (EVH) is between 12.73 to 30.61 according to relative valuation method.

How does EVH's valuation metrics compare to the industry average?

The average P/S ratio for EVH's competitors is 0.61, providing a benchmark for relative valuation. Evolent Health Inc Corp (EVH) exhibits a P/S ratio of 0.19, which is -68.09% above the industry average. Given its robust revenue growth of -27.50%, this premium appears unsustainable.

What is the current P/B ratio for Evolent Health Inc (EVH) as of Mar 02 2026?

As of Mar 02 2026, Evolent Health Inc (EVH) has a P/B ratio of 0.52. This indicates that the market values EVH at 0.52 times its book value.

What is the current FCF Yield for Evolent Health Inc (EVH) as of Mar 02 2026?

As of Mar 02 2026, Evolent Health Inc (EVH) has a FCF Yield of -26.72%. This means that for every dollar of Evolent Health Inc's market capitalization, the company generates -26.72 cents in free cash flow.

What is the current Forward P/E ratio for Evolent Health Inc (EVH) as of Mar 02 2026?

As of Mar 02 2026, Evolent Health Inc (EVH) has a Forward P/E ratio of 16.41. This means the market is willing to pay $16.41 for every dollar of Evolent Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Evolent Health Inc (EVH) as of Mar 02 2026?

As of Mar 02 2026, Evolent Health Inc (EVH) has a Forward P/S ratio of 0.19. This means the market is valuing EVH at $0.19 for every dollar of expected revenue over the next 12 months.

EVH Valuation